Epidemiology of pneumococcal serotypes and conjugate vaccine formulations

Microbial Drug Resistance

Volumn 3, Issue 2, 1997, Pages 125-130

  Butler, Jay C ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BACTERIAL POLYSACCHARIDE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PROTEIN;

ANTIBIOTIC SENSITIVITY; ANTIBODY RESPONSE; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; CHILD; CLINICAL TRIAL; CROSS REACTION; DRUG FORMULATION; HUMAN; IMMUNOGENICITY; INFANT; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SEROPREVALENCE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BACTERIA (MICROORGANISMS); PNEUMOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030994511     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1997.3.125     Document Type: Article

References (18)

1. Adams, W.G., K.A. Deaver, S.L. Cochi, B.D. Plikaytis, E.R. Zell, C.V. Broome, J.D. Wenger, for the Haemophilus influenzae Study Group. 1993. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 269:221-226.
2. Anderson, E.L., D.J. Kennedy, K.M. Geldmacher, J. Donnelly, and P.M. Mendelman. 1996. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J. Pediatr. 128:649-653.
3. Austrian, R., R.M. Douglas, G. Schiffman, A.M. Coetzee, H.J. Koornhof, S. Hayden-Smith, and R.D.W. Reid. 1976. Prevention of pneumococcal pneumonia by vaccination. Trans. Assoc. Am. Physicians 89:184-194.
4. Baltimore, R.S., and E.D. Shapiro. 1991. Pneumococcal infections. In A.S. Evans and P.S. Brachman (ed.), Bacterial infections of humans: Epidemiology and control. Plenum Medical Book Co., New York, pp. 525-546.
5. Barry, M.A., D.E. Craven, and M. Finland. 1984. Serotypes of Streptococcus pneumoniae isolated from blood cultures at Boston City Hospital between 1979 and 1982. J. Infect. Dis. 149:449-452.
6. Bennett, N.M., J. Buffington, and F.M. LaForce. 1992. Pneumococcal bacteremia in Monroe County, New York. Am. J. Public Health 82:1513-1516.
7. Black, S.B., H.R. Shinefield, D. Lampert, B. Fireman, R.A. Hiatt, M. Polen, E. Vittinghoff, and the Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. 1991. Safety and immunogenicity of oligosacharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. Pediatr. Infect. Dis. J. 10:92-96.
8. Breiman, R.F., J.S. Spika, V.J. Navarro, P.M. Darden, and C.P. Darby. 1990. Pneumococcal bacteremia in Charleston County, South Carolina. Arch. Intern. Med. 150:1401-1405.
9. Broome, C.V., and R.R. Facklam. 1981. Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States. Rev. Infect. Dis. 3:277-280.
10. Butler, J.C., R.F. Breiman, H.B. Lipman, J. Hofmann, and R.R. Facklam. 1995. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: Implications for development of a conjugate vaccine. J. Infect. Dis. 171:885-889.
11. Butler, J.C., R.F. Breiman, J.F. Campbell, H.B. Lipman, C.V. Broome, and R.R. Facklam. 1993. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recombination. JAMA 270:1826-1831.
12. Catalán, M.J., J.M. Fernández, A. Vazquea, E. Varela de Seijas, A. Suárez, and J.C.L. Bernaldo de Quirós. 1994. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin. Infect. Dis. 18:766-769.
13. Dagan, R., R. Melamed, M. Muallem, L. Piglansky, D. Greenberg, O. Abramson, P.M. Mendelman, N. Bohidar, and P. Yagupsky. 1996. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugte pneumococcal vaccine. J. Infect. Dis. 174:1271-1278.
14. Douglas, R.M., J.C. Paton, S.J. Duncan, and D.J. Hansman. 1984. Antibody response to pneumococcal vaccination in children younger than five years of age. J. Infect. Dis. 149:861-869.
15. Eskola, J., H. Käyhty, A.K. Takala, H. Peltola, P.R. Rönnberg, E. Kela, E. Pekkanen, P.H. McVerry, and P.H. Mäkelä. 1990. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N. Engl. J. Med. 323:1381-1387.
16. Finland, M., and M.W. Barnes. 1977. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J. Clin. Microbiol. 5:154-166.
17. Friedland, I.R., and K.P. Klugman. 1992. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 339:405-408.
18. Friedland, I.R. 1995. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr. Infect. Dis. J. 14:885-890.